Compare IDA & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDA | ICLR |
|---|---|---|
| Founded | 1915 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 9.3B |
| IPO Year | 1998 | 2001 |
| Metric | IDA | ICLR |
|---|---|---|
| Price | $141.78 | $113.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $142.86 | ★ $178.62 |
| AVG Volume (30 Days) | 422.4K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | ★ 7.27 | N/A |
| EPS | ★ 5.90 | N/A |
| Revenue | ★ $1,746,972,000.00 | N/A |
| Revenue This Year | $10.92 | N/A |
| Revenue Next Year | $7.71 | N/A |
| P/E Ratio | $24.08 | ★ $12.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $111.12 | $66.57 |
| 52 Week High | $149.73 | $211.00 |
| Indicator | IDA | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 48.43 |
| Support Level | $139.58 | $99.11 |
| Resistance Level | $145.08 | $116.85 |
| Average True Range (ATR) | 2.35 | 6.38 |
| MACD | -0.52 | -0.82 |
| Stochastic Oscillator | 26.72 | 25.00 |
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The company's only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which are involved in food processing, electronics and general manufacturing, agriculture, health care, government, education, and information technology.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.